Politico November 22, 2024
Driving The Day
BIOSECURE CHECK-IN — Legislation that would curtail Chinese biotechnology companies’ ability to do business in the U.S. has significant bipartisan backing, but division among key GOP members is complicating its path forward.
A major reason for questions about its future is Sen. Rand Paul (R-Ky.), the incoming chair of the Homeland Security Committee, who has steadfastly opposed the legislation. Lawmakers — including House Speaker Mike Johnson and retiring Rep. Brad Wenstrup (R-Ohio) — are preparing a last-ditch effort to get the BIOSECURE Act signed into law with weeks left in this Congress.
The bill, which passed the House overwhelmingly in September, would halt federal contracts for companies partnering with named Chinese biotech companies. Wenstrup and other supporters...
Today's Sponsors
Today's Sponsor